CAS RN: 918524-63-7
1-Methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine
Product Availability
Choose a grade to view its available package options.
4 package records4 with current stock1 grade group
| Batch No. | Package | Availability | Inquiry |
| Batchno.20250323 |
1g |
In stock |
Inquiry |
| Batchno.20260226 |
250mg |
In stock |
Inquiry |
| Batchno.20250827 |
25g |
In stock |
Inquiry |
| Batchno.20251226 |
5g |
In stock |
Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 5g, 0.25g, 10g, 25g
- Available purity: ≥97%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 918524-63-7
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
≥97% |
5
In Stock
|
Beijing |
Inquiry |
| 5g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
≥97% |
2
In Stock
|
Shenzhen |
Inquiry |
| 10g |
≥97% |
2
In Stock
|
Hong Kong |
Inquiry |
| 25g |
≥97% |
1
In Stock
|
Hong Kong |
Inquiry |
918524-63-7 / 1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine
Standard CAS: 918524-63-7
Multi CAS: Yes
Basic Information
CAS
918524-63-7
Multi CAS
Yes
Molecular Formula
BC16H26N3O2
Molecular Weight
303.200000
Exact Mass
303.211807
InChI
InChI=1S/C16H26BN3O2/c1-15(2)16(3,4)22-17(21-15)13-6-7-14(18-12-13)20-10-8-19(5)9-11-20/h6-7,12H,8-11H2,1-5H3
InChIKey
KVQXFNGVIIPCSX-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
22
Aromatic heavy atom count
6
Fraction Csp3
0.69
Rotatable bonds
2
H-bond acceptors
5
Molar refractivity
89.66
TPSA
37.83
LogP / Solubility
WLOGP
1.13
MLOGP
1.01
XLogP3
1.13
Consensus LogP
1.09
Log S (ESOL)
-2.5
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.86
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.81
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.77
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2.5